USD 4.81 Billion
Report ID:
SQMIG35H2261 |
Region:
Global |
Published Date: September, 2024
Pages:
203
|Tables:
0
|Figures:
0
Global Cell line development Market was valued at USD 4.81 Billion in 2022 and is expected to rise from USD 5.28 Billion in 2023 to USD 11.16 Billion by 2031, at a CAGR of 9.8% during the forecast period (2024–2031).
Growing investments in the development of novel cell technologies and products coupled with advancements in cell technologies are projected to primarily drive cell line development market growth. Rising demand for personalized medicine and high investments in cell research around the world also create new opportunities for cell line development providers. Rapidly expanding demand for biosimilars and biologics to treat various diseases will also create new opportunities for cell line development companies. Rising emphasis on the development of new pharmaceuticals, therapeutics and vaccines to improve overall healthcare is also estimated to boost the demand for cell line development over the coming years. Rising use of gene editing technologies is projected to present highly lucrative opportunities for cell line development companies in the long run. However, high costs of development, ethical concerns, and roadblocks in scalability are projected to impede cell line development demand outlook across the study period and beyond.
Global Market Size
USD 4.81 Billion
Largest Segment
Tissue engineering
Fastest Growth
Drug discovery
Growth Rate
9.8% CAGR
To get more reports on the above market click here to Buy The Report
The cell line development market is segmented based on the type, source, product and service, application, and region. Based on the type, the cell line development market is segmented into recombinant cell lines, hybridomas, continuous cell lines, primary cell lines. Based on the Application, the market is segmented into bioproduction, drug discovery, toxicity testing, tissue engineering, others. Based on the product and service, the market is segmented into reagents & media, accessories and consumables, equipment, services. On the basis of source, the market is divided into mammalian cell line and non-mammalian cell line. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
Analysis by Product and Service
Reagents and media are projected to account for a notable share of the global cell line development market. High use of reagents and media in almost all stages of cell line development and its crucial role in expanding the application scope of cell line development are all expected to help this segment maintain its high market share. Crucial role of reagents and media in drug development, toxicity testing, and other applications will also help this segment bring in major revenue going forward.
On the other hand, the demand for cell line development services is forecasted to rise at a robust pace across the forecast period and beyond. Surging emphasis on development of novel biosimilars and patent expiration of renowned biologics are projected to promote market growth via this segment. Moreover, increasing number of biotechnology companies outsourcing their operations and work is also estimated to favor the demand for cell line development services in the future.
Analysis by Application
Bioproduction is projected to account for a dominant share of cell line development demand over the coming years. High use of cell line development for the development of biologics, vaccines, biosmilars, and gene therapies is projected to help this segment maintain its high market share. Growing investments in the development of novel biopharmaceuticals and therapeutics around the world are projected to help bioproduction application maintain its dominant stance in the future.
Meanwhile, the use of cell line development for tissue engineering applications is projected to surge at an impressive pace across the study period. Rising demand for personalized medicine and growing demand for organ transplantation are projected to create new opportunities for cell line development companies via this segment. High investments in the research and development of novel tissue engineering technologies will also create opportunities for cell line development providers in the long run.
To get detailed analysis on other segments, Request For Free Sample Report
North America is estimated to lead the demand for cell line development in the world owing to high investments in medical R&D and the presence of a developed healthcare infrastructure. Presence of key biotechnology companies and supportive government initiatives to advanced medical research are also expected to create new opportunities for cell line development companies. Growing awareness regarding benefits of novel biologics and increased adoption of the same will also help this region’s dominance. The United States is projected to be the top market for cell line development companies in this region.
Asia Pacific region is slated to emerge as the most opportune market for cell line development companies on a global level. Presence of key contract research organizations, low costs of research, supportive regulatory frameworks, and increasing healthcare expenditure are key factors that are forecasted to create new opportunities for cell line development companies in this region. Rapidly increasing investments in healthcare infrastructure development and growing awareness regarding healthcare will also bolster cell line development market growth in the future. China, Japan, and India are slated to be the most lucrative markets in this region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
High Investments in Cell Research
Demand for Personalized Medicine
Restraints
High Costs of Development
Ethical Concerns and Regulatory Challenges
Request Free Customization of this report to help us to meet your business objectives.
Creating cell lines for specific applications will help companies maximize their business scope and also set them apart from the competition. Developing novel cell line development products and services will also help boost market growth over the coming years. Cell line development companies can take advantage of supportive government initiatives and funding to maximize their business scope in the long run.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, growing investments in cell research and rising demand for personalized medicine are projected to bolster the demand for cell line development over the coming years. On the contrary, high costs of development and stringent regulations are estimated to slow down market growth potential across the study period. North America is forecasted to spearhead the global demand for cell line development owing to presence of key biotechnology companies and high investments in cell research. Cell line development market players can explore the use of advanced technologies to maximize their business potential in the future.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 4.81 Billion |
Market size value in 2031 | USD 11.16 Billion |
Growth Rate | 9.8% |
Base year | 2023 |
Forecast period | 2024–2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Cell Line Development Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Line Development Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Line Development Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell Line Development Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2261